Zhengrong Shui
No. 283, Tongzipo Road
Changsha, 410013, China
Changsha, 410013, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Beyond clinical trials: CDK4/6 inhibitor efficacy predictors and nomogram model from real-world evidence in metastatic breast cancer.
Journal: Cancer innovation
Published: April 11, 2024
Exploring the clinical outcomes and safety profile of inetetamab treatment in metastatic breast cancer patients: A multicenter assessment of a Chinese-origin recombinant Anti-HER2 monoclonal antibody.
Journal: Breast (Edinburgh, Scotland)
Published: September 21, 2023
The treatment pattern of advanced HR-positive and HER2-negative breast cancer in central southern China: a hospital-based cross-sectional study.
Journal: BMC cancer
Published: September 20, 2023
A randomized trial of eribulin monotherapy versus eribulin plus anlotinib in patients with locally recurrent or metastatic breast cancer.
Journal: ESMO open
Published: March 21, 2023
Significant response to the combination of pyrotinib and letrozole in a patient with metastatic HER2-positive and hormone receptor-positive breast cancer: a case report.
Journal: Annals of palliative medicine
Published: August 13, 2021
FGFR aberrations increase the risk of brain metastases and predict poor prognosis in metastatic breast cancer patients.
Journal: Therapeutic advances in medical oncology
Published: October 22, 2019
In Vivo Detection of CTC and CTC Plakoglobin Status Helps Predict Prognosis in Patients with Metastatic Breast Cancer.
Journal: Pathology oncology research : POR
Published: July 09, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026